A Cancer Diagnosis May Affect Diabetics’ Medication Adherence

Diabetics may become less adherent to diabetes medications following a cancer diagnosis, a new study shows. There was a 6.3% drop in patients’ Medication Possession Ratio (MPR) (an indicator for medication adherence) at the time of cancer diagnosis, plus an ongoing monthly decline in MPR of 0.20% after diagnosis. The largest drops in MPR at the time of cancer diagnosis were seen among patients with stage IV cancer and gastrointestinal or pulmonary cancers. The Diabetologia study included 52,228 new users of glucose-lowering drugs, including 3281 who developed cancer during follow-up and 12,891 who did not.

Category:
Subcategory:
Body:

Diabetics may become less adherent to diabetes medications following a cancer diagnosis, a new study shows. There was a 6.3% drop in patients’ Medication Possession Ratio (MPR) (an indicator for medication adherence) at the time of cancer diagnosis, plus an ongoing monthly decline in MPR of 0.20% after diagnosis. The largest drops in MPR at the time of cancer diagnosis were seen among patients with stage IV cancer and gastrointestinal or pulmonary cancers. The Diabetologia study included 52,228 new users of glucose-lowering drugs, including 3281 who developed cancer during follow-up and 12,891 who did not.

Area(s) of Interest: